Klaas de Boer

Klaas de Boer currently works at General Fusion, Inc., as Chairman from 2020, Xeros Technology Group Plc, as Chairman from 2020, CelLBxHealth Plc, as Non-Executive Director from 2026, SmartKem, Inc., as Independent Director from 2021, SmartKem Ltd., as Director from 2017, and General Fusion Group Ltd., as Independent Director.
Mr. de Boer also formerly worked at Heliocentris Fuel Cell Solutions GmbH, as Vice Chairman, Heliocentris Energy Solutions AG, as Vice Chairman-Supervisory Board from 2015 to 2016, OptiNose, Inc., as Director, Entrepreneurs Fund Management Services, as Managing Director, Prosonix Ltd., as Non-Executive Director, 20, as Director, ProtAffin Biotechnologie AG, as Director-Supervisory Board from 2009 to 2014, Optinose AS, as Director, inge GmbH, as Director, n-Tec AS, as Director, Technolas Perfect Vision GmbH, as Director, Preferred Global Health, Inc., as CIO & Marketing Director, The New Motion BV, as Director, Oomph Wellness Ltd., as Director, D3O Holdings Ltd., as Director, Lifeline Scientific, Inc., as Non-Executive Director from 2008 to 2016, Vanenburg Group BV, as Business Development Manager, vasopharm GmbH, as Member-Supervisory Board, Entrepreneurs Fund Management LLP, as Managing Partner from 2006 to 2021, and The Makers BV (Netherlands), as Managing Partner.
Mr. de Boer received his Masters Business Admin degree in 1993 from INSEAD and graduate degree in 1990 from Delft University of Technology.